These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2483222

  • 1. Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia.
    Lubrano C, Petrangeli E, Catizone A, Santonati A, Concolino G, Rombolá N, Frati L, Di Silverio F, Sciarra F.
    J Steroid Biochem; 1989; 34(1-6):499-504. PubMed ID: 2483222
    [Abstract] [Full Text] [Related]

  • 2. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
    Sciarra F.
    Ann N Y Acad Sci; 1995 Jun 12; 761():66-78. PubMed ID: 7542859
    [Abstract] [Full Text] [Related]

  • 3. Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods.
    Maddy SQ, Chisholm GD, Hawkins RA, Habib FK.
    J Endocrinol; 1987 Apr 12; 113(1):147-53. PubMed ID: 2438365
    [Abstract] [Full Text] [Related]

  • 4. Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia.
    Lubrano C, Toscano V, Petrangeli E, Spera G, Trotta MC, Rombolà N, Frati L, Di Silverio F, Sciarra F.
    J Steroid Biochem Mol Biol; 1993 Oct 12; 46(4):463-8. PubMed ID: 7692939
    [Abstract] [Full Text] [Related]

  • 5. Sex steroid receptors in normal and hyperplastic human prostate.
    Robel P, Eychenne B, Blondeau JP, Baulieu EE, Hechter O.
    Prostate; 1985 Oct 12; 6(3):255-67. PubMed ID: 2581236
    [Abstract] [Full Text] [Related]

  • 6. Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate.
    Davies P, Eaton CL.
    Prostate; 1989 Oct 12; 14(2):123-32. PubMed ID: 2469072
    [Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor receptors in human hyperplastic prostate tissue and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.
    Fiorelli G, De Bellis A, Longo A, Natali A, Costantini A, Serio M.
    J Clin Endocrinol Metab; 1989 Apr 12; 68(4):740-3. PubMed ID: 2466042
    [Abstract] [Full Text] [Related]

  • 8. Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptors.
    Lubrano C, Sciarra F, Spera G, Petrangeli E, Toscano V, Rombola N, Palleschi F, Palma E, Di Silverio F.
    J Steroid Biochem Mol Biol; 1992 Mar 12; 41(3-8):683-7. PubMed ID: 1373303
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor is not the major growth-promoting agent in extracts of prostatic tissue.
    Story MT, Jacobs SC, Lawson RK.
    J Urol; 1983 Jul 12; 130(1):175-9. PubMed ID: 6191046
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor: receptor binding and effects on the sex accessory organs of sexually mature male mice.
    Liu A, Davis RJ, Flores C, Menon M, Seethalakshmi L.
    J Urol; 1992 Aug 12; 148(2 Pt 1):427-31. PubMed ID: 1635153
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour.
    Maddy SQ, Chisholm GD, Busuttil A, Habib FK.
    Br J Cancer; 1989 Jul 12; 60(1):41-4. PubMed ID: 2478180
    [Abstract] [Full Text] [Related]

  • 14. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J, Hicks LL, Walsh PC.
    J Clin Invest; 1980 May 12; 65(5):1051-9. PubMed ID: 6154062
    [Abstract] [Full Text] [Related]

  • 15. Steroid hormone receptors and endocrine response of prostatic carcinoma.
    Jasper WS, Abou-Issa H, Gogate SA, Snider GB.
    Cancer Detect Prev; 1987 May 12; 10(5-6):393-9. PubMed ID: 2436783
    [Abstract] [Full Text] [Related]

  • 16. [Epidermal growth factor binding and steroid receptor content in human benign prostatic hypertrophy].
    Lubrano C, Sciarra A, Armellini S, Flammia GP, Wongher L, Caponera M.
    Minerva Urol Nefrol; 1992 May 12; 44(1):9-14. PubMed ID: 1382322
    [No Abstract] [Full Text] [Related]

  • 17. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue.
    Glynne-Jones E, Goddard L, Harper ME.
    Hum Pathol; 1996 Jul 12; 27(7):688-94. PubMed ID: 8698313
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS.
    Cancer Res; 1984 Aug 12; 44(8):3448-53. PubMed ID: 6331648
    [Abstract] [Full Text] [Related]

  • 19. Steroid receptor content in cytosol from normal and hyperplastic human prostates.
    Ekman P, Snochowski M, Dahlberg E, Bression D, Högberg B, Gustafsson JA.
    J Clin Endocrinol Metab; 1979 Aug 12; 49(2):205-15. PubMed ID: 88456
    [Abstract] [Full Text] [Related]

  • 20. Measurement of occupied and non-occupied epidermal growth factor receptor sites in 216 human breast cancer biopsies.
    Falette N, Lefebvre MF, Meggouh F, Eynard M, Garin E, Saez S.
    Breast Cancer Res Treat; 1992 Mar 12; 20(3):177-83. PubMed ID: 1571570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.